Jun H. Cai
600 Tianhe Road
Guangzhou, 510630, China
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Mechanisms, optimization strategies, and salvage options for CAR-T cell therapy.
Journal: Biomarker research
Published: May 14, 2026
Artemether alleviates Aβ1-42-induced neuronal cell damage via PGC-1α-mediated mitochondrial homeostasis in Alzheimer's disease.
Journal: Cellular signalling
Published: April 28, 2026
Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T-Cell Lymphoma.
Journal: American journal of hematology
Published: February 05, 2026
Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial.
Journal: Nature communications
Published: December 24, 2025
Anti-PD-1 antibody combined with P-GEMOX chemotherapy versus P-GEMOX chemotherapy with or without autologous stem-cell transplantation for previously untreated advanced natural killer/T cell lymphoma: a retrospective cohort study.
Journal: Blood cancer journal
Published: September 25, 2025
A revised staging system for natural killer/T cell lymphoma incorporating skull base invasion and nasal/non-nasal subtype distinction.
Journal: Cell reports. Medicine
Published: September 01, 2025
Serum triglyceride and apolipoprotein A1 as dynamic biomarkers in extranodal NK/T-cell lymphoma (ENKTL): A multicenter retrospective and prospective validation study.
Journal: Annals of hematology
Published: July 21, 2025
Single-cell profiling of natural killer/T-cell lymphoma reveals stratified immune features and potential therapeutic implications.
Journal: Nature communications
Published: July 07, 2025
LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 27, 2025
Nutritional composition dataset of approved infant formula powder in China (2017-2024).
Journal: Data in brief
Published: May 27, 2025
TQB3617, a bromodomain and extra-terminal inhibitor, in patients with relapsed or refractory lymphoma: A multicenter, phase 1 trial.
Journal: Med (New York, N.Y.)
Published: May 08, 2025
Antiviral prophylaxis for hepatitis B virus reactivation in T-cell lymphoma patients with resolved hepatitis B virus infection.
Journal: International journal of cancer
Published: May 05, 2025
Last Updated: 09/26/2026